MedPath
HSA Approval

CINNARON 25 TABLET 25 mg

SIN02924P

CINNARON 25 TABLET 25 mg

CINNARON 25 TABLET 25 mg

May 22, 1989

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N07CA02

cinnarizine

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

CINNARIZINE

25 mg

Cinnarizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CINNARON 25 TABLET 25 mg - HSA Approval | MedPath